BiotechTube
Home/Xitra Therapeutics/Thomas Walther, PhD
TW

Thomas Walther, PhD

General Manager (Xitra GmbH); CEO (Constant Therapeutics LLC)

Xitra Therapeutics

Therapeutic Areas

Rare DiseasesInflammatory DiseasesPediatric Diseases

Xitra Therapeutics Pipeline

DrugIndicationPhase
Mas/MrgD Agonist ProgramCongenital Muscular DystrophyPre-clinical